Latest News- Cushing Syndrome Market: Hospital pharmacy is expected to lead the Distribution Channel segment during 2025-2029

The Cushing Syndrome Market is being driven by Growing geriatric population

The Cushing Syndrome Market is expected to grow at a CAGR of 23.3% during 2024 and 2029. During this period, the market is also expected to show a growth of USD 2005.6 million. According to the National Organization for Rare Disorders, approximately 13 individuals per million experience endogenous Cushing Syndrome annually. This condition, primarily caused by adrenal or pituitary tumors, disproportionately affects women. The aging population, representing a high-risk group for hormonal disorders, is expanding due to advancements in technology and increased life expectancy. This demographic shift significantly burdens public healthcare systems with increased spending on healthcare for the aging population, including those with Cushing Syndrome. 

Get more information on Cushing Syndrome Market by requesting a sample report

Which Factors Are Causing a Surge in Market Growth?

The market is segmented based on

• Distribution Channel
  • Hospital pharmacy
  • Retail pharmacy
  • Online pharmacy
• Type
  • Glucocorticoid receptor antagonists
  • Pituitary directed drugs
  • Steroidogenesis inhibitors
• Customer Type
  • Adults
  • Pediatrics
• Geography
  • North America
    • Canada
    • Mexico
    • US
  • Europe
    • Germany
    • UK
    • France
    • Italy
  • Asia
    • China
    • Japan
  • Rest of World (ROW)

According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows: 

• Growing geriatric population
• Rising drug development for Cushing syndrome treatment
• Favorable reimbursement scenario of Cushing syndrome treatment

However, the market also witnesses some limitations, which are as follows:

• Limited patient pool for clinical trials
• Dearth of skilled professionals for Cushing syndrome treatment
• Delayed diagnosis and lack of awareness of Cushing syndrome

Benefits of Buying Global Cushing Syndrome Market Research Report by Technavio

Rich Experience: 20+ years leading global market research, trusted insights across industries.

Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.

Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.

Market Scope in Cushing Syndrome Market Research Report

Request Free Sample

Find out which segment is leading the market by accessing the free PDF report

Research Analysis Overview

Cushing's syndrome, also known as Cushing's disease, is a hormonal disorder caused by excessive production of cortisol, a corticosteroid hormone. This condition, often linked to tumors in the adrenal glands or pituitary gland, results in inflammation, weight gain, adipose tissue deposits, purple and reddish stretch marks, thin skin, acne, high blood pressure, abdominal obesity, round red face, weak muscles, weak bones, and delicate skin. Common treatments include corticosteroid medication like Prednisone, surgery, radiation, and chemotherapy. The geriatric population and individuals with autoimmune diseases are more susceptible. Complications may include type 2 diabetes and drug approvals for new treatments are ongoing.

Market Research Overview

The Cushing Syndrome market falls under the broader pharmaceuticals sector, encompassing entities involved in the research and development (R&D) or production of various drug types, including generic and non-generic medications, as well as veterinary drugs. According to Technavio, the global pharmaceuticals market's growth is influenced by several factors, including an aging population. By 2050, approximately one-quarter of the US and European populations are projected to be over 60 years old. This demographic shift, driven by increasing life expectancy, will fuel market expansion. Cushing's disease and syndrome, characterized by cortisol overproduction and corticosteroid medication usage, are associated with conditions such as inflammation and weight gain, including adipose tissue deposits. These conditions are prevalent in older populations, further boosting market demand.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/